Anti-inflammatory, immunomodulatory and antinociceptive activity of terminalia arjuna roxb bark powder in mice and rats

Indian Journal of Experimental Biology

Volumn 47, Issue 7, 2009, Pages 577-583

  Halder, Sumita ^a   Bharal, Nidhi ^a   Mediratta, Pramod K ^a   Kaur, Inderjeet ^a   Sharma, Krishna K ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Anti inflammatory; Antinociception; Formalin induced pain response; Humoral immune response; Tail flick latency test; Terminalia arjuna

Indexed keywords

ANALGESIC AGENT; IMMUNOLOGIC FACTOR; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTICLE; AYURVEDA; BARK; DRUG EFFECT; DRUG TOLERANCE; EDEMA; MALE; MOUSE; PAIN THRESHOLD; PHYTOTHERAPY; POWDER; RAT; TERMINALIA; WISTAR RAT;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG TOLERANCE; EDEMA; IMMUNOLOGIC FACTORS; MALE; MEDICINE, AYURVEDIC; MICE; MORPHINE; PAIN THRESHOLD; PHYTOTHERAPY; PLANT BARK; POWDERS; RATS; RATS, WISTAR; TERMINALIA;

ANIMALIA; MUS; RATTUS; TERMINALIA; TERMINALIA ARJUNA;

EID: 70349318060     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Meng CQ, Atherosclerosis is an inflammatory disorder after all, Curr Topics Med Chem, 6 (2006) 93.
2. (Pubitemid 44297753) Stoll G & Bendszus M, Inflammation and atherosclerosis: novel insights into plaque formation and destabilization, Stroke, 37 (2006) 1923.
3. (Pubitemid 40776619) Sugano R, Matsuoka H, Haramaki N, Umei H, Murase E, Fukami K, Iida S, Ikeda H & Imaizumi T, Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies, Arterioscler Thromb Vasc Biol, 25 (2005) 1262.
4. Chopra R N, Chopra I C & Handa K L, Indigenous drugs of India, edited by LD Kapur (Academic Publishers, India), 1994, 421
5. (Pubitemid 34664291) Bharani A, Ganguli A, Mathur L K, Jamra Y & Raman P G, Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing terminalia arjuna with isosorbide mononitrate, Indian Heart J, 54 (2002) 170.
6. Dwivedi S, Putative uses of Indian cardiovascular friendly plants in preventive cardiology, Ann Natl Academy Med Sci (India), 32 (1996) 159.
7. Gupta R, Singhal S, Goyal A & Sharma V N, Antioxidant and hypocholesterolemic effects of Terminalia arjuna treebark powder:A randomised placebo controlled trial, J Assoc Physicians India, 49 (2001) 231.
8. (Pubitemid 32962659) Sumitra M, Manikandan P, Kumar D A, Arutselven N, Balakrishna K, Manohar B M & Puvanakrishnan R, Experimental myocardial necrosis in rats:role of arjunolic acid on platelet aggregation, coagulation and antioxidant status, Mol Cell Biochem, 224 (2001) 135.
9. (Pubitemid 27122303) Ram A, Lauria P, Gupta R, Kumar P & Sharma V N, Hypocholesterolaemic effects of Terminalia arjuna tree bark, J Ethnopharmacol, 55 (1997) 165.
10. (Pubitemid 23160295) Radhakrishnan R, Wadsworth R M & Goyal A L, Terminalia arjuna, ayurvedic cardiotonic increases contractile force of rat isolated atria, Phytother Res, 7 (1993) 266.
11. Srivastava R D, Dwivedi S, Sreenivasan K K & Chandrashekharan C N, Cardiovascular effects of Terminalia species of plant, Indian Drugs, 29 (1992) 144.
12. (Pubitemid 12016567) Singh N, Kapur K K, Singh S P, Shankar K, Sinha J N & Kohli R P, Mechanism of cardiovascular action of Terminalia arjuna, Planta Med, 45 (1982) 102.
13. Chaturvedi P N, A study on the effect of an indigenous drug Arjuna (Terminalia arjuna Wand A) on arterial thrombosis and ishaemic heart disease, Thesis (Doctor of Ayurvedic Medicine), Banaras Hindu University, Varanasi, 1967.
14. (Pubitemid 41556590) Gauthaman K, Banerjee S K, Dinda A K, Ghosh C C & Maulik S K, Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: role of antioxidant enzymes and heat shock protein, J Ethnopharmacol, 96 (2005) 403.
15. (Pubitemid 39118430) Bharani A, Ahirwar L K & Jain N, Terminalia arjuna reverses impaired endothelial function in chronic smokers, Indian Heart J, 56 (2004) 123.
16. Bharani A, Ganguly A & Bhargava K D, Salutary effect of Terminalia arjuna in patients with severe refractory heart failure, Int J Cardiol, 49 (1995) 191.
17. (Pubitemid 37092669) Mary N K, Babu B H & Padikkala J, Antiatherogenic effect of Caps HT2, a herbal Ayurvedic medicine formulation, Phytomedicine, 10 (2003) 474.
18. (Pubitemid 38955111) Tripathi Y B, Reddy M M, Pandey R S, Subhashini J, Tiwari O P, Singh B K & Reddanna P, Anti-inflammatory properties of BHUx, a polyherbal formulation to prevent atherosclerosis, Inflammopharmacology, 12 (2004) 131.
19. (Pubitemid 28100250) Dwivedi S & Jauhari R, Beneficial effects of Terminalia arjuna in coronary artery disease, Indian Heart J, 49 (1997) 507.
20. (Pubitemid 16124979) Kulkarni S K, Mehta A K & Kunchandy J, Antiinflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw oedema in rats, Arch Int Pharmacodyn Ther, 279 (1986) 324.
21. Winter C A, Risley E A & Nuss G W, Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs, Proc Soc Exp Biol Med, 111 (1962) 544.
22. (Pubitemid 44959693) Vasudevan M, Gunnam K K & Parle M, Antinociceptive and anti-inflammatory effects of Thespesia populnea bark extract, J Ethnopharmacol, 109 (2007) 264.
23. (Pubitemid 34226635) Mediratta P K, Sharma K K & Singh S, Evaluation of immunomodulatory potential of Ocimum sanctum seed oil and its possible mechanism of action, J Ethnopharmacol, 80 (2002) 15.
24. D'amour F E & Smith D L, A method of determining loss of pain sensation, J Pharmacol Exp Ther, 72 (1941) 74.
25. Abbott F V, Franklin K B & Westbrook R F, The formalin test: scoring properties of the first and second phases of the pain response in rats, Pain, 60 (1995) 91.
26. Libby P, Geng Y J, Aikawa M, Schoenbeck U, Mach F, Clinton S K, Sukhova G K & Lee R T, Macrophages and atherosclerotic plaque stability, Curr Opin Lipidol, 7 (1996) 330.
27. (Pubitemid 32291406) Libby P & Simon D I, Inflammation and thrombosis: the clot thickens, Circulation, 103 (2001) 1718.
28. (Pubitemid 32666962) Libby P, Current concepts of the pathogenesis of the acute coronary syndromes, Circulation, 104 (2001) 365.
29. Dwivedi S & Agarwal M P, Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug in coronary artery disease, J Assoc Physicians India, 42 (1994) 287.
30. (Pubitemid 28035440) Safayhi H & Sailer E R, Anti-inflammatory actions of pentacyclic triterpenes, Planta Med, 63 (1997) 487.
31. (Pubitemid 39130598) Altman R, Risk factors in coronary atherosclerosis atheroinflammation: the meeting point, Thromb J, 1 (2003) 4.
32. (Pubitemid 43040127) Sivalokanathan S, Ilayaraja M & Balasubramanian M P, Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats, Mol Cell Biochem, 281 (2006) 87.
33. Nair S, Nagar R & Gupta R, Anti-oxidant phenolics and flavonoids in common Indian foods, J Assoc Physicians India, 46 (1998) 708.
34. (Pubitemid 39050246) Chander R, Singh K, Khanna A K, Kaul S M, Puri A & Saxena R, Antidyslipidemic and antioxidant activities of different fractions of Terminalia arjuna stem bark, Indian J Clin Biochem, 19 (2004) 141.
35. Mansour A, Fox C A, Akil H & Watson S J, Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications, Trends Neurosci, 18 (1995) 22.
36. Houdi A A, Pierzchala K, Marson L, Palkovits M & Van Loon G R, Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity, Peptides 12 (1991) 161.
37. (Pubitemid 2035848) Polastron J, Meunier J C & Jauzac P, Chronic morphine induces tolerance and desensitization of mu-opioid receptor but not down-regulation in rabbit, Eur J Pharmacol, 266 (1994) 139.
38. (Pubitemid 18064397) Porro C A, Facchinetti F, Pozzo P, Benassi C, Biral G P & Genazzani A R, Tonic pain time-dependently affects betaendorphin-like immunoreactivity in the ventral periaqueductal gray matter of the rat brain, Neurosci Lett, 86 (1988) 89.
39. (Pubitemid 15239047) Fasmer O B, Berge O G & Hole K, Changes in nociception after lesions of descending serotonergic pathways induced with 5, 6-dihydroxytryptamine, Different effects in the formalin and tail-flick tests, Neuropharmacology, 24 (1985) 729.
40. Tjølsen A, Lund A & Hole K, Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems, Eur J Pharmacol, 193 (1991) 193.
41. Tjølsen A, Berge O G, Hunskaar S, Rosland J H & Hole K, The formalin test: an evaluation of the method, Pain, 51 (1992) 5.
42. (Pubitemid 30151642) Sacerdote P, Manfredi B, Gaspani L & Panerai A E, The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in BALB/cJ mice, Blood, 95 (2000) 2031.
43. Eisenstein T K & Hilburger M E, Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations, J Neuroimmunol, 83 (1998) 36.
44. Mediratta P K, Das N, Gupta V S & Sen P, Modulation of humoral immune response by endogenous opioids, J Allergy Clin Immunol, 81 (1988) 27.